Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
478 |
|
|||
481 |
|
|||
485 |
|
Pathway Name | Organism |
---|---|
Signaling by ALK fusions and activated point mutants | Homo sapiens |
Signaling by CSF1 (M-CSF) in myeloid cells | Homo sapiens |
Signaling by LTK | Homo sapiens |
Signaling by LTK in cancer | Homo sapiens |
Signaling by PDGFRA extracellular domain mutants | Homo sapiens |
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | Homo sapiens |
Synthesis of PIPs at the plasma membrane | Homo sapiens |
Tie2 Signaling | Homo sapiens |
VEGFA-VEGFR2 Pathway | Homo sapiens |
DO ID | Disease Name | Source |
---|---|---|
DOID:0080522 | thyroid gland anaplastic carcinoma | |
DOID:0080531 | dedifferentiated liposarcoma | |
DOID:0080548 | Noonan syndrome with multiple lentigines 1 | |
DOID:0090018 | autosomal dominant familial periodic fever | |
DOID:0090021 | split hand-foot malformation 1 | |
DOID:0090053 | episodic kinesigenic dyskinesia 1 | |
DOID:0090103 | Huntington's disease-like 1 | |
DOID:0090104 | Huntington's disease-like 2 | |
DOID:0110035 | Alzheimer's disease 2 | |
DOID:0110037 | Alzheimer's disease 5 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024